1. Home
  2. ARTNA vs LRMR Comparison

ARTNA vs LRMR Comparison

Compare ARTNA & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Artesian Resources Corporation

ARTNA

Artesian Resources Corporation

HOLD

Current Price

$31.92

Market Cap

346.0M

Sector

Utilities

ML Signal

HOLD

Logo Larimar Therapeutics Inc.

LRMR

Larimar Therapeutics Inc.

HOLD

Current Price

$3.94

Market Cap

332.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTNA
LRMR
Founded
1905
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
346.0M
332.1M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
ARTNA
LRMR
Price
$31.92
$3.94
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$16.71
AVG Volume (30 Days)
24.6K
1.4M
Earning Date
10-30-2025
11-05-2025
Dividend Yield
3.92%
N/A
EPS Growth
12.02
N/A
EPS
2.18
N/A
Revenue
$111,776,000.00
N/A
Revenue This Year
$7.82
N/A
Revenue Next Year
$3.54
N/A
P/E Ratio
$14.66
N/A
Revenue Growth
5.80
N/A
52 Week Low
$29.45
$1.61
52 Week High
$36.19
$6.48

Technical Indicators

Market Signals
Indicator
ARTNA
LRMR
Relative Strength Index (RSI) 56.10 55.08
Support Level $30.89 $3.12
Resistance Level $31.70 $4.09
Average True Range (ATR) 0.60 0.25
MACD 0.15 0.07
Stochastic Oscillator 88.95 79.13

Price Performance

Historical Comparison
ARTNA
LRMR

About ARTNA Artesian Resources Corporation

Artesian Resources Corp operates as a holding company with a focus on water distribution and wastewater services. Its regulated utility segment includes subsidiaries providing water and wastewater services in Delaware, Maryland, and Pennsylvania. Water distribution spans residential, commercial, industrial, and municipal sectors, while wastewater services are offered in Sussex County, Delaware. The company also engages in non-utility businesses, offering service line protection plans, engineering services, and contract operations for water and wastewater systems. The regulated utility segment constitutes the portion of the company's operations, subject to regulations by Delaware, Maryland, and Pennsylvania.

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

Share on Social Networks: